Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Clasificación en acciones #12697
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Precio por acción
$2.04
Capitalización bursátil
$122.58M
Cambio (1 día)
4.48%
Cambio (1 año)
-1.05%
País
FR
Comercio Crossject Société Anonyme (ALCJ)

Categoría

Historial del precio de la acción de Crossject Société Anonyme (ALCJ)
Precio más alto de cierre: $2.05 el 2026-07-01

Precio más bajo de cierre: $14.25 el 2014-02-01
Historial del precio de la acción de Crossject Société Anonyme desde 2014 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 11.39%
2025 -0.35%
2024 -57.35%
2023 37.09%
2022 20.21%
2021 -26.70%
2020 75.54%
2019 63.37%
2018 -70.52%
2017 2.47%
2016 -46.89%
2015 -15.92%
2014 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$406.78 -20.56%
US
$203.31 -28.00%
FR
$55.43 6.36%
DE
$155.72 28.74%
JP
$151.94 -13.66%
US